Zhou YB - Search Results

1

A novel GSK-3β inhibitor YQ138 prevents neuronal injury induced by glutamate and brain ischemia through activation of the Nrf2 signaling pathway.

Pang T, Wang YJ, Gao YX, Xu Y, Li Q, Zhou YB, Xu L, Huang ZJ, Liao H, Zhang LY, Gao JR, Ye Q, Li J. Pang T, et al. Among authors: zhou yb. Acta Pharmacol Sin. 2016 Jun;37(6):741-52. doi: 10.1038/aps.2016.3. Epub 2016 Apr 25. Acta Pharmacol Sin. 2016. PMID: 27108601 Free PMC article.

2

Discovery and characterization of a novel inhibitor of CDC25B, LGH00045.

Feng X, Wang LN, Zhou YY, Yu HP, Shen Q, Zang Y, Zhou YB, Li JY, Zhang HX, Li J. Feng X, et al. Among authors: zhou yb, zhou yy. Acta Pharmacol Sin. 2008 Oct;29(10):1268-74. doi: 10.1111/j.1745-7254.2008.00841.x. Acta Pharmacol Sin. 2008. PMID: 18817634

3

LGH00031, a novel ortho-quinonoid inhibitor of cell division cycle 25B, inhibits human cancer cells via ROS generation.

Zhou YB, Feng X, Wang LN, Du JQ, Zhou YY, Yu HP, Zang Y, Li JY, Li J. Zhou YB, et al. Among authors: zhou yy. Acta Pharmacol Sin. 2009 Sep;30(9):1359-68. doi: 10.1038/aps.2009.131. Acta Pharmacol Sin. 2009. PMID: 19730430 Free PMC article.

4

Rubiyunnanins C-H, cytotoxic cyclic hexapeptides from Rubia yunnanensis inhibiting nitric oxide production and NF-κB activation.

Fan JT, Su J, Peng YM, Li Y, Li J, Zhou YB, Zeng GZ, Yan H, Tan NH. Fan JT, et al. Among authors: zhou yb. Bioorg Med Chem. 2010 Dec 1;18(23):8226-34. doi: 10.1016/j.bmc.2010.10.019. Epub 2010 Oct 31. Bioorg Med Chem. 2010. PMID: 21044847

5

Novel microtubule-targeted agent 6-chloro-4-(methoxyphenyl) coumarin induces G2-M arrest and apoptosis in HeLa cells.

Ma YM, Zhou YB, Xie CM, Chen DM, Li J. Ma YM, et al. Among authors: zhou yb. Acta Pharmacol Sin. 2012 Mar;33(3):407-17. doi: 10.1038/aps.2011.176. Epub 2012 Jan 23. Acta Pharmacol Sin. 2012. PMID: 22266726 Free PMC article.

6

The anomeric mixture of some O-galactolipid derivatives is more toxic against cancer cells than either anomer alone.

Song SX, Wu ML, He XP, Zhou YB, Sheng L, Li J, Chen GR. Song SX, et al. Among authors: zhou yb. Bioorg Med Chem Lett. 2012 Mar 1;22(5):2030-2. doi: 10.1016/j.bmcl.2012.01.069. Epub 2012 Jan 28. Bioorg Med Chem Lett. 2012. PMID: 22326167

7

Design, synthesis, and evaluation of 3-aryl-4-pyrrolyl-maleimides as glycogen synthase kinase-3β inhibitors.

Ye Q, Li M, Zhou YB, Cao JY, Xu L, Li YJ, Han L, Gao JR, Hu YZ, Li J. Ye Q, et al. Among authors: zhou yb. Arch Pharm (Weinheim). 2013 May;346(5):349-58. doi: 10.1002/ardp.201300008. Epub 2013 Apr 15. Arch Pharm (Weinheim). 2013. PMID: 23585245

8

Characterization of a novel curcumin analog P1 as potent inhibitor of the NF-κB signaling pathway with distinct mechanisms.

Peng YM, Zheng JB, Zhou YB, Li J. Peng YM, et al. Among authors: zhou yb. Acta Pharmacol Sin. 2013 Jul;34(7):939-50. doi: 10.1038/aps.2013.2. Epub 2013 Apr 22. Acta Pharmacol Sin. 2013. PMID: 23603982 Free PMC article.

9

Synthesis and biological evaluation of 3-benzisoxazolyl-4-indolylmaleimides as potent, selective inhibitors of glycogen synthase kinase-3β.

Ye Q, Li M, Zhou Y, Pang T, Xu L, Cao J, Han L, Li Y, Wang W, Gao J, Li J. Ye Q, et al. Molecules. 2013 May 13;18(5):5498-516. doi: 10.3390/molecules18055498. Molecules. 2013. PMID: 23669633 Free PMC article.

10

Berberine combined with 2-deoxy-d-glucose synergistically enhances cancer cell proliferation inhibition via energy depletion and unfolded protein response disruption.

Fan LX, Liu CM, Gao AH, Zhou YB, Li J. Fan LX, et al. Among authors: zhou yb. Biochim Biophys Acta. 2013 Nov;1830(11):5175-83. doi: 10.1016/j.bbagen.2013.07.010. Epub 2013 Jul 18. Biochim Biophys Acta. 2013. PMID: 23872355

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

644 results

Search Page

Filters